A Prospective Long-term Observational Study in Patients With Monoclonal Gammopathy of Undetermined Significance

RecruitingOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

September 6, 2023

Primary Completion Date

December 1, 2026

Study Completion Date

December 1, 2032

Conditions
MGUS
Trial Locations (1)

OX3 7LE

RECRUITING

Secure Study, Oxford

All Listed Sponsors
lead

Oxford University Hospitals NHS Trust

OTHER